Park Ha Biological Technology Co., Ltd. (PHH)

PHH Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Year Ending	TTM	Oct 31, 2023	Oct 31, 2022
Cash & Equivalents	0.93	1.03	0.57
Short-Term Investments	0.49	0.32	1.39
Cash & Cash Equivalents	1.42	1.35	1.97
Cash Growth	-	-31.25%	-
Receivables	0.15	0.36	0.12
Inventory	-	0.1	0.09
Other Current Assets	0.25	0.37	0.09
Total Current Assets	1.83	2.18	2.26
Property, Plant & Equipment	-	0.04	0.04
Goodwill and Intangibles	-	0.04	0.04
Other Long-Term Assets	-	0.01	0.18
Total Long-Term Assets	-	0.09	0.25
Total Assets	-	2.26	2.52
Accounts Payable	-	0.2	0.13
Current Debt	-	0.09	0.79
Other Current Liabilities	1.07	0.96	1.45
Total Current Liabilities	1.07	1.24	2.37
Long-Term Debt	-	0.01	-
Total Long-Term Liabilities	-	0.01	0
Total Liabilities	-	1.25	2.37
Total Debt	0.12	0.1	0.79
Debt Growth	-	-87.32%	-
Retained Earnings	-	-0.11	-0.93
Comprehensive Income	-	-0.07	-0.05
Shareholders' Equity	1.07	1.01	0.15
Net Cash / Debt	1.29	1.25	1.18
Net Cash / Debt Growth	-	6.08%	-
Working Capital	0.76	0.93	-0.1

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).